# NOSIP

## Overview
The NOSIP gene encodes the nitric oxide synthase interacting protein, a regulatory protein that plays a significant role in modulating the activity of nitric oxide synthases (NOS), particularly endothelial NOS (eNOS) and neuronal NOS (nNOS). As a cytoplasmic and nuclear protein, NOSIP influences the localization and activity of these enzymes by promoting their translocation within the cell, thereby affecting nitric oxide (NO) production. This translocation is crucial for cellular processes such as the cell cycle and synaptic plasticity. NOSIP's interactions with eNOS and nNOS are mediated through specific binding to the carboxyl-terminal region of the NOS oxygenase domain, and it competes with other proteins like caveolin-1 for binding sites. The gene's expression is dynamically regulated, reflecting its involvement in various physiological and pathological processes, including craniofacial development, neurogenesis, and inflammatory responses (Dreyer2004Nitric; DEDIO2001NOSIP; Schleicher2005Cell).

## Function
NOSIP (nitric oxide synthase interacting protein) plays a crucial role in the regulation of nitric oxide synthase (NOS) activity, particularly endothelial NOS (eNOS) and neuronal NOS (nNOS). In endothelial cells, NOSIP modulates eNOS activity by promoting its translocation from the plasma membrane to intracellular compartments, such as the cytoskeleton, which reduces nitric oxide (NO) production. This translocation is significant during the G2 phase of the cell cycle, where NOSIP targets eNOS to the actin cytoskeleton, thereby inhibiting its enzymatic activity (Schleicher2005Cell). NOSIP's interaction with eNOS is facilitated by its binding to the carboxyl-terminal region of the eNOS oxygenase domain (DEDIO2001NOSIP).

In neurons, NOSIP interacts with nNOS, affecting its distribution and activity. It reduces nNOS activity by sequestering it away from synaptic sites, which may influence synaptic plasticity and transmission (Dreyer2004Nitric). NOSIP's expression is dynamically regulated by neuronal activity, suggesting a role in controlling NO synthesis in response to changes in neuronal signaling (Dreyer2004Nitric). NOSIP is active in both the cytoplasm and nucleus, with its nucleocytoplasmic shuttling influencing its regulatory functions (Schleicher2005Cell).

## Clinical Significance
Mutations and alterations in the NOSIP gene have been linked to several developmental and inflammatory conditions. In craniofacial development, NOSIP knockout mice exhibit severe defects such as cyclopia, cleft lip, and palate, which are more pronounced than in other models of holoprosencephaly (HPE). This suggests that NOSIP is crucial for proper craniofacial and forebrain development, making it a candidate for genetic analysis in humans with HPE (Hoffmeister2014The). 

NOSIP is also implicated in neurogenesis, where its absence leads to microcephaly due to reduced brain size and cortical thickness, as well as diminished formation of postmitotic neurons and neural progenitor cells (Hoffmeister2017Developmental). 

In the context of inflammation, a novel polymorphism in NOSIP affects nitric oxide production and is associated with increased mortality in sepsis patients. This polymorphism leads to higher expression of inflammatory cytokines and chemokines, suggesting a role for NOSIP in modulating inflammatory responses (Mukherjee2016A). 

NOSIP's interaction with nitric oxide synthases, particularly its modulation of inducible nitric oxide synthase (iNOS), further underscores its significance in inflammatory pathways and potential therapeutic targeting (Mukherjee2016A).

## Interactions
NOSIP (nitric oxide synthase interacting protein) is known for its interaction with endothelial nitric oxide synthase (eNOS), where it binds specifically to the carboxyl-terminal region of the eNOS oxygenase domain. This interaction has been confirmed through coimmunoprecipitation studies both in vitro and in vivo (DEDIO2001NOSIP). NOSIP modulates eNOS activity by promoting its translocation from the plasma membrane to intracellular compartments, thereby inhibiting nitric oxide (NO) production (DEDIO2001NOSIP; Schleicher2005Cell). 

NOSIP competes with caveolin-1 for binding to eNOS, as both proteins interact with overlapping regions on the eNOS oxygenase domain. A synthetic peptide of the caveolin-1 scaffolding domain can inhibit the NOSIP-eNOS interaction, indicating competitive binding (Kone2003Protein; DEDIO2001NOSIP). 

NOSIP also interacts with neuronal nitric oxide synthase (nNOS), although this interaction is weaker compared to eNOS, suggesting a potential regulatory role in neuronal NOS activity as well (DEDIO2001NOSIP; Schleicher2005Cell). NOSIP's interactions are crucial for its role in modulating nitric oxide synthase activity and localization within cells.


## References


[1. (DEDIO2001NOSIP) JÜRGEN DEDIO, PETER KÖNIG, PAULUS WOHLFART, CHRISTIAN SCHROEDER, WOLFGANG KUMMER, and WERNER MÜLLER-ESTERL. Nosip, a novel modulator of endothelial nitric oxide synthase activity. The FASEB Journal, 15(1):79–89, January 2001. URL: http://dx.doi.org/10.1096/fj.00-0078com, doi:10.1096/fj.00-0078com. This article has 139 citations.](https://doi.org/10.1096/fj.00-0078com)

[2. (Hoffmeister2017Developmental) Meike Hoffmeister, Julia Krieg, Alexander Ehrke, Franziska A. Seigfried, Lisa Wischmann, Petra Dietmann, Susanne J. Kühl, and Stefanie Oess. Developmental neurogenesis in mouse and xenopus is impaired in the absence of nosip. Developmental Biology, 429(1):200–212, September 2017. URL: http://dx.doi.org/10.1016/j.ydbio.2017.06.026, doi:10.1016/j.ydbio.2017.06.026. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ydbio.2017.06.026)

[3. (Schleicher2005Cell) Michael Schleicher, Fredrik Brundin, Steffen Gross, Werner Müller-Esterl, and Stefanie Oess. Cell cycle-regulated inactivation of endothelial no synthase through nosip-dependent targeting to the cytoskeleton. Molecular and Cellular Biology, 25(18):8251–8258, September 2005. URL: http://dx.doi.org/10.1128/mcb.25.18.8251-8258.2005, doi:10.1128/mcb.25.18.8251-8258.2005. This article has 31 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.25.18.8251-8258.2005)

[4. (Kone2003Protein) Bruce C. Kone, Teresa Kuncewicz, Wenzheng Zhang, and Zhi-Yuan Yu. Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide. American Journal of Physiology-Renal Physiology, 285(2):F178–F190, August 2003. URL: http://dx.doi.org/10.1152/AJPRENAL.00048.2003, doi:10.1152/ajprenal.00048.2003. This article has 400 citations and is from a peer-reviewed journal.](https://doi.org/10.1152/AJPRENAL.00048.2003)

[5. (Hoffmeister2014The) Meike Hoffmeister, Carola Prelle, Philipp Küchler, Igor Kovacevic, Markus Moser, Werner Müller-Esterl, and Stefanie Oess. The ubiquitin e3 ligase nosip modulates protein phosphatase 2a activity in craniofacial development. PLoS ONE, 9(12):e116150, December 2014. URL: http://dx.doi.org/10.1371/journal.pone.0116150, doi:10.1371/journal.pone.0116150. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0116150)

6. (Mukherjee2016A) A novel polymorphism in nitric oxide synthase interacting protein (NOSIP) modulates nitric oxide and mortality in Human Sepsis. This article has 1 citations.

[7. (Dreyer2004Nitric) Jacqueline Dreyer, Michael Schleicher, Anke Tappe, Kirstin Schilling, Thomas Kuner, Grace Kusumawidijaja, Werner Müller-Esterl, Stefanie Oess, and Rohini Kuner. Nitric oxide synthase (nos)-interacting protein interacts with neuronal nos and regulates its distribution and activity. The Journal of Neuroscience, 24(46):10454–10465, November 2004. URL: http://dx.doi.org/10.1523/JNEUROSCI.2265-04.2004, doi:10.1523/jneurosci.2265-04.2004. This article has 116 citations.](https://doi.org/10.1523/JNEUROSCI.2265-04.2004)